Sugargic PM 1mg/500mg/15mg Tablet SR
Marketer
Neorangic Healthcare Private Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Sugargic PM 1mg/500mg/15mg Tablet SR
Diabetol PM 1mg/500mg/15mg Extended-Release Tablets combine medications to manage blood glucose. This formulation, used alongside diet and exercise, enhances glycemic control in adult patients with type 2 diabetes. It facilitates improved insulin utilization, resulting in lower blood sugar. Follow your physician's prescribed dosage and regimen for Diabetol PM. Administer with food to minimize gastrointestinal discomfort. If a dose is missed, take it promptly unless the next dose is imminent; then, omit the missed dose and resume the regular schedule. Never double the dose. Overdosage can cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol, or skipped meals may increase the risk of hypoglycemia. Regular blood sugar monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating women should seek medical counsel. Kidney function tests will be conducted before treatment initiation. Limit alcohol consumption to reduce the likelihood of adverse reactions.
Uses of Sugargic PM 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Sugargic PM 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Consume Sugargic PM 1mg/500mg/15mg Extended-Release Tablet with food.
Common Side effects of Sugargic PM 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Sugargic PM 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Sugargic PM 1mg/500mg/15mg Extended-Release Tablet with a meal.
How Sugargic PM 1mg/500mg/15mg Tablet SR works:
Sugargic PM 1mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple combination enhances blood glucose management when single or dual drug therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts via reduced hepatic glucose production, slowed intestinal glucose absorption, and improved insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Sugargic PM 1mg/500mg/15mg SR tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Sugargic PM 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against any possible hazards prior to prescribing this medication. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Sugargic PM 1mg/500mg/15mg tablet may pose a risk to breastfeeding infants. Available human data indicates potential transfer to breast milk, with possible adverse effects on the nursing child.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use the extended-release Sugargic PM 1mg/500mg/15mg tablet cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Close monitoring of renal function is recommended during treatment. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Sugargic PM 1mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician before use. Sugargic PM 1mg/500mg/15mg Tablet SR is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Sugargic PM 1mg/500mg/15mg Tablet SR :
Should you forget a Sugargic PM 1mg/500mg/15mg SR Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sugargic PM 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently